TREM2 and Alzheimer disease: On the other hand, a study on 33 cases, including 11 AD cases, reported TREM2-immunoreactive microglia associated with plaques; this study employed a different polyclonal anti-TREM2 antibody (R&D AF1828) (Lue et al., 2015).